Akshay Vaishnaw

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Junlin Ho, Attorney-in-Fact for Akshay Vaishnaw
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Akshay Vaishnaw:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scholar Rock Holding Corp President of R&D, Director Common Stock 616K $18.5M $30.01 29 May 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. President Common Stock 22.8K $4.22M $185.32 04 Aug 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. President Restricted Stock Units 5.79K $1.07M $185.32 27 Feb 2023 Direct
ALNYLAM PHARMACEUTICALS, INC. President Common Stock 515 $95.4K $185.32 03 Aug 2023 by Managed Account
Scholar Rock Holding Corp President of R&D, Director Stock Option (Right to Buy) 110K 02 May 2025 Direct
Editas Medicine, Inc. Director Stock Option (right to buy) 25K 30 May 2024 Direct
ALNYLAM PHARMACEUTICALS, INC. President Stock Option (right to buy) 12K 27 Feb 2023 Direct

Insider Reports Filed by Akshay Vaishnaw

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SRRK Scholar Rock Holding Corp 29 May 2025 2 -$201K 4 President of R&D, Director 30 May 2025, 16:30
SRRK Scholar Rock Holding Corp 02 May 2025 1 $0 4 President of R&D, Director 06 May 2025, 17:01
SRRK Scholar Rock Holding Corp 27 Apr 2025 2 $0 4 President of R&D, Director 29 Apr 2025, 18:08
SRRK Scholar Rock Holding Corp 27 Jun 2024 2 $0 4 Director 01 Jul 2024, 17:32
EDIT Editas Medicine, Inc. 30 May 2024 1 $0 4 Director 03 Jun 2024, 16:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2023 8 -$754K 4 President 07 Aug 2023, 18:04
SRRK Scholar Rock Holding Corp 21 Jun 2023 1 $0 4 Director 22 Jun 2023, 19:11
EDIT Editas Medicine, Inc. 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 16:30
ALNY ALNYLAM PHARMACEUTICALS, INC. 26 Apr 2023 6 -$465K 4 President 28 Apr 2023, 17:54
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2023 2 $0 4 President 01 Mar 2023, 15:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 10 Feb 2023 7 -$6.27M 4 President 14 Feb 2023, 15:03
ALNY ALNYLAM PHARMACEUTICALS, INC. 05 Dec 2022 7 $449 4 President 07 Dec 2022, 15:09
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2022 7 -$1.16M 4 President 05 Aug 2022, 16:13
SRRK Scholar Rock Holding Corp 16 Jun 2022 1 $0 4 Director 21 Jun 2022, 17:04
EDIT Editas Medicine, Inc. 09 Jun 2022 1 $0 4 Director 13 Jun 2022, 16:30
SRRK Scholar Rock Holding Corp 26 May 2022 1 $0 4 Director 27 May 2022, 16:35
ALNY ALNYLAM PHARMACEUTICALS, INC. 23 Feb 2022 1 $0 4 President 25 Feb 2022, 15:11
ALNY ALNYLAM PHARMACEUTICALS, INC. 31 Dec 2021 1 $0 4 President 04 Jan 2022, 15:04
ALNY ALNYLAM PHARMACEUTICALS, INC. 21 Dec 2021 21 -$1.03M 4 President, R&D 23 Dec 2021, 16:23
ALNY ALNYLAM PHARMACEUTICALS, INC. 09 Aug 2021 3 -$1.48M 4 President, R&D 11 Aug 2021, 16:10
ALNY ALNYLAM PHARMACEUTICALS, INC. 18 Jun 2021 5 -$1.85M 4 President, R&D 22 Jun 2021, 16:07
EDIT Editas Medicine, Inc. 03 Jun 2021 1 $0 4 Director 07 Jun 2021, 16:16
SRRK Scholar Rock Holding Corp 27 May 2021 1 $0 4 Director 01 Jun 2021, 16:10